-
Views
-
Cite
Cite
Colleen Hadigan, James B. Meigs, Peter W. F. Wilson, Ralph B. D'Agostino, Benjamin Davis, Nesli Basgoz, Paul E. Sax, Steven Grinspoon, Prediction of Coronary Heart Disease Risk in HIV-Infected Patients with Fat Redistribution, Clinical Infectious Diseases, Volume 36, Issue 7, 1 April 2003, Pages 909–916, https://doi.org/10.1086/368185
- Share Icon Share
Abstract
A metabolic syndrome has been described among human immunodeficiency virus (HIV)-infected patients receiving highly active antiretroviral therapy; the syndrome is characterized by fat redistribution, insulin resistance, and dyslipidemia. We compared the 10-year coronary heart disease (CHD) risk estimates for 91 HIV-infected men and women with fat redistribution with the risk estimates for 273 age-, sex-, and body mass index (BMI)-matched subjects enrolled in the Framingham Offspring Study. Thirty HIV-infected patients without fat redistribution were also compared with 90 age- and BMI-matched control subjects. The 10-year CHD risk estimate was significantly elevated among HIV-infected patients with fat redistribution, particularly among men; however, when they were matched with control subjects by waist-to-hip ratio, the 10-year CHD risk estimate did not significantly differ between groups. HIV-infected patients without fat redistribution did not have a greater CHD risk estimate than did control subjects. In addition, the CHD risk estimate was greatest in HIV-infected patients who had primary lipoatrophy, compared with those who had either lipohypertrophy or mixed fat redistribution. Therefore, although CHD risk is increased in HIV-infected patients with fat redistribution, the pattern of fat distribution and sex are potential important components in determining the risk in this population.